NR565 Advanced Pharmacology: Endocrine,
Respiratory, GI, and CAM – Qs & As
Save Groups
Practice questions for this set
Learn 1 /7 Study using Learn
Fasting glucose >/= 126; random plasma glucose >/=200 plus symptoms of DM;
glucose tolerance test 2h mark >/=200; Hgb A1c 6.5% or higher
Choose an answer
1 ADA 2023 guidelines 2 Exam Format
3 Pioglitazone contraindications 4 Testing Timeframe
Don't know?
Terms in this set (69)
Exam Format Non-Cumulative Exam
Question Type Multiple Choice
Number of Questions 100
, Time Allotted 120 minutes (1.2 minutes per question)
Testing Timeframe The final exam will be available starting on
Wednesday Week 8 at 12:01 am MT until Saturday
Week 8 at 11:59 pm MT.
Week 5 Coverage Pharmacotherapy for Endocrine Disorders
Radioactive iodine adverse effects Hypothyroidism due to excessive thyroid damage
(delayed)
Hypothyroidism incidence Up to 90% of patients have hypothyroidism within the
first year after exposure
Methimazole indication First-line for hyperthyroidism, except for pregnant or
breastfeeding patients
Methimazole MOA Prevents oxidation of iodide, inhibiting incorporation
of iodine into tyrosine; prevents iodinated tyrosines
from coupling
Levothyroxine education Take once daily 30 to 60 minutes before breakfast.
Separate by 4 hours from drugs such as H2 receptor
blockers, PPIs, antacids, iron and calcium.
Levothyroxine monitoring Target TSH is 0.4 to 4
Pioglitazone contraindications NYHA class III and IV; Type 1 DM (needs insulin to
work)
Gemfibrozil drug interactions Displaces warfarin from plasma albumin, increasing
anticoagulant effects
Insulin detemir dosing U-100 once or twice a day at same time each day
Insulin glargine administration Once daily subQ dosing to treat adults and children
with T1D and adults with T2D.
Respiratory, GI, and CAM – Qs & As
Save Groups
Practice questions for this set
Learn 1 /7 Study using Learn
Fasting glucose >/= 126; random plasma glucose >/=200 plus symptoms of DM;
glucose tolerance test 2h mark >/=200; Hgb A1c 6.5% or higher
Choose an answer
1 ADA 2023 guidelines 2 Exam Format
3 Pioglitazone contraindications 4 Testing Timeframe
Don't know?
Terms in this set (69)
Exam Format Non-Cumulative Exam
Question Type Multiple Choice
Number of Questions 100
, Time Allotted 120 minutes (1.2 minutes per question)
Testing Timeframe The final exam will be available starting on
Wednesday Week 8 at 12:01 am MT until Saturday
Week 8 at 11:59 pm MT.
Week 5 Coverage Pharmacotherapy for Endocrine Disorders
Radioactive iodine adverse effects Hypothyroidism due to excessive thyroid damage
(delayed)
Hypothyroidism incidence Up to 90% of patients have hypothyroidism within the
first year after exposure
Methimazole indication First-line for hyperthyroidism, except for pregnant or
breastfeeding patients
Methimazole MOA Prevents oxidation of iodide, inhibiting incorporation
of iodine into tyrosine; prevents iodinated tyrosines
from coupling
Levothyroxine education Take once daily 30 to 60 minutes before breakfast.
Separate by 4 hours from drugs such as H2 receptor
blockers, PPIs, antacids, iron and calcium.
Levothyroxine monitoring Target TSH is 0.4 to 4
Pioglitazone contraindications NYHA class III and IV; Type 1 DM (needs insulin to
work)
Gemfibrozil drug interactions Displaces warfarin from plasma albumin, increasing
anticoagulant effects
Insulin detemir dosing U-100 once or twice a day at same time each day
Insulin glargine administration Once daily subQ dosing to treat adults and children
with T1D and adults with T2D.
